Centene Corporation’s Stock Price Plummets to $61.29, Witnessing a Sharp 5.45% Drop

Centene Corporation (CNC)

61.29 USD -3.53 (-5.45%) Volume: 8.44M

Centene Corporation’s stock price stands at 61.29 USD, experiencing a dip of -5.45% this trading session with a trading volume of 8.44M, however, maintaining a positive year-to-date change of +1.17%, reflecting a steady performance amidst market fluctuations.

Latest developments on Centene Corporation

Centene Corp‘s stock price movements today can be attributed to a mix of positive and negative news. The company reported strong Q4 earnings, beating estimates with an EPS of $0.56 and revenue surpassing expectations at $40.8 billion. Membership growth and controlled medical expenses contributed to the positive results. However, Centene’s shares slipped due to higher Medicaid costs. Despite this, the company raised its 2025 revenue outlook, indicating confidence in future performance. Additionally, Centene donated to the Trump inaugural fund and key lawmakers, further influencing market sentiment. Analysts are optimistic, giving Centene a “Moderate Buy” rating and insiders have been buying shares, showing faith in the company’s potential.

Centene Corporation on Smartkarma

Analysts on Smartkarma, like Baptista Research, are optimistic about Centene Corp‘s future. In a recent research report titled “Centene Corporation: Operational Efficiency & AI Utilization Driving Our Optimism! – Major Drivers,” they highlighted the company’s third-quarter financial results for 2024. Despite facing ongoing challenges, Centene Corp exceeded expectations with an adjusted diluted EPS of $1.62. This outperformance was attributed to the realization of tax benefits earlier than projected, along with accelerated income tax benefits.

A look at Centene Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Centene Corporation’s long-term outlook appears to be positive, with high scores in value and growth according to Smartkarma Smart Scores. The company is well-positioned in terms of its value proposition and potential for future growth. However, its low score in the dividend category may deter income-focused investors. Centene’s resilience and momentum scores are average, indicating a moderate level of stability and market performance.

Centene Corporation is a multi-line managed care organization that offers Medicaid and Medicaid-related programs across multiple states. In addition to health plans, the company provides specialized services such as behavioral health and nurse triage. With strong scores in value and growth, Centene shows promise for long-term success in the managed care industry, despite lower scores in dividend yield. Investors may want to consider the company’s overall outlook and strategic positioning before making investment decisions.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma